## SHW: Sherwin-Williams Company (The) - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -4.8% below STRENGTH zone (4.0-10.0%); PEG 3.31 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($313.19)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Assessing Sherwin-Williams (SHW) Valuation After Its Recent Share Price Pullback**
- Source: Simply Wall Street | 20251209T123859 | Somewhat-Bullish | Relevance: 98%
- Sherwin-Williams (SHW) shares have recently pulled back, showing an 8.5% decline over 90 days, despite continued earnings and revenue growth. While a narrative-driven valuation suggests the stock is 15.4% undervalued with a fair value of $386.52, current market ratios indicate it's expensive at 31.4 times earnings compared to industry averages. This discrepancy prompts investors to consider whether the stock is an undervalued opportunity or if its premium is unsustainable.

**2. Sherwin-Williamsâ€™ Big Year of Business Expansion and Economic Challenges**
- Source: Cleveland Magazine | 20251208T100323 | Neutral | Relevance: 97%
- Sherwin-Williams is undergoing a significant transformation with the phased move into its new Cleveland headquarters and the Morikis Global Technology Center. The company faced financial challenges in 2025 due to weakened sales, economic pressures, mounting costs for its "Building Our Future" program, and new federal tariffs, leading to voluntary layoffs and a suspension of 401K matches. Despite these hurdles, the new facilities and a return-to-office mandate signal a period of renewed business activity and innovation for the paint manufacturer.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 16 ($0.21M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 36.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 9.1% (+1.4%)
- Blackrock Inc.: 7.1% (-0.7%)
- State Street Corpora: 6.2% (-0.9%)
- Price (T.Rowe) Assoc: 3.6% (-1.7%)
- Morgan Stanley: 2.9% (+1.8%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.3% 5d) with bearish MACD, trend may be turning.
2. Valuation stretched: PEG 3.3x requires aggressive growth execution.
3. Long-term trend broken: trading 5.8% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.31 signals overvaluation risk, limited margin of safety. Forward P/E 25.8x stretched relative to 11% growth. Quality metrics strong (ROE 60%). Balance sheet: $1.1B free cash flow. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $81.3B |
| Beta | 1.24 |
| 52W Range | $308.84 - $379.65 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.31 |
| Forward P/E | 25.8 |
| Current P/E | 28.7 |
| YoY Growth | 11.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -2.5% to -4.8% (-2.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.8pp (needs >4.0% for momentum thesis). Underperforming sector by 3.6pp, stock-specific weakness. Below SMA200 (0.94x), long-term trend not supportive. MACD histogram bearish (-1.39), momentum weakening. RSI neutral at 41.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.82% (CS: 17) | Weak |
| RSI_14 | 40.9 | Neutral |
| MACD Histogram | -1.39 | Bearish |
| vs SMA20 | 0.975x | Below |
| vs SMA50 | 0.968x | Below |
| vs SMA200 | 0.942x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $326.27
- **Stop Loss:** $313.19 (4.0% risk)
- **Target:** $339.35 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 91
- **Position Value:** $29,690.57
- **Portfolio %:** 29.69%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2026-02-03 (Est: $2.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.44 | $3.59 | +4.4% |
| 2025Q2 | $3.81 | $3.38 | -11.2% |
| 2025Q1 | $2.16 | $2.25 | +4.1% |
| 2024Q4 | $2.06 | $2.09 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*